Related Experiment Videos
Laboratory testing on cerebrospinal fluid. A reappraisal
This study analyzed 555 cases of cerebrospinal fluid testing to determine when additional tests are useful. It found that when basic parameters like opening pressure, cell count, and protein are normal, further tests rarely contribute to diagnosis or treatment. Only three patients with multiple sclerosis had useful results from additional tests. In cases of meningitis, abnormal results were common, but exceptions occurred in immunocompromised patients and those with childhood bacterial meningitis. The study suggests that clinicians should limit additional tests when basic parameters are normal but consider them in specific patient groups.
Area of Science:
- Neurology diagnostic techniques
- Clinical laboratory testing
- Infectious disease diagnostics
Background:
Current diagnostic practices for cerebrospinal fluid often include a wide range of tests. Prior research has shown that many additional tests beyond basic parameters like opening pressure, cell count, and protein yield limited diagnostic benefit. This gap motivated a detailed review of clinical cases to determine when additional tests are truly useful. Established knowledge indicates that basic CSF parameters are frequently abnormal in infectious and malignant meningitis. However, the value of additional tests in immunocompromised patients or those with multiple sclerosis remains unclear. No prior work had resolved how often these extra tests lead to actionable results. This paper's contribution is a systematic analysis of 555 cases to clarify when further testing is necessary. The study focuses on how often additional CSF tests influence diagnosis or treatment decisions. It also addresses the uncertainty around the diagnostic value of these tests in specific patient groups.
Purpose Of The Study:
The aim of this study is to evaluate the diagnostic and therapeutic utility of cerebrospinal fluid tests beyond basic parameters. The specific problem is the overuse of additional CSF tests in cases where they may not contribute to diagnosis or treatment. The motivation is to reduce unnecessary testing and improve clinical decision-making. The study focuses on 555 consecutive cases where CSF was submitted for cell count. It seeks to determine when additional tests are indicated based on patient characteristics and clinical context. The goal is to identify patterns in test utility across different diagnostic categories. The researchers propose that most additional tests are not useful when basic parameters are normal. They also aim to highlight exceptions in specific patient populations.
Main Methods:
The study design is a retrospective review of 555 cases where CSF was submitted for cell count. The primary tools were medical records and CSF test results. The approach involved categorizing cases based on diagnostic outcomes and test results. The researchers grouped patients into two main categories: those with normal basic parameters and those with abnormal results. They analyzed the number of additional tests performed and their diagnostic impact. The data included 1385 additional tests in cases with normal opening pressure, cell count, and protein. The study also focused on 148 cases of bacterial, chronic infectious, and malignant meningitis. The analysis compared test utility across patient subgroups, including immunocompromised individuals.
Main Results:
Among 334 cases with normal opening pressure, cell count, and protein, 1385 additional tests were performed. Only three patients (0.9%) had findings that influenced diagnosis or treatment. These were cases of multiple sclerosis. In 148 cases of bacterial, chronic infectious, and malignant meningitis, abnormal results were observed in all but three. Two were childhood bacterial meningitis cases and one was cryptococcal meningitis in an immunocompromised patient. The study found that additional CSF tests are rarely useful when basic parameters are normal. However, exceptions exist in immunocompromised patients and those with possible multiple sclerosis or childhood bacterial meningitis. The results suggest that most additional tests do not contribute to clinical decisions. The findings highlight the importance of clinical context in determining test utility.
Conclusions:
The authors state that normal opening pressure, cell count, and protein in CSF usually indicate no need for additional tests. They suggest that in most cases, further testing is not indicated when these parameters are normal. However, exceptions may apply in immunocompromised patients or those with possible multiple sclerosis or childhood bacterial meningitis. The study concludes that additional CSF tests are rarely useful in the absence of abnormal basic parameters. The findings support a more selective approach to CSF testing. The authors propose that clinicians should consider patient-specific factors when deciding on additional tests. The study does not claim that all additional tests are unnecessary, but that their utility is limited in most cases. The implications are primarily for clinical practice and diagnostic testing protocols.
Frequently Asked Questions
The study found that additional CSF tests are rarely useful when basic parameters like opening pressure, cell count, and protein are normal.
The study reviewed 555 consecutive cases where cerebrospinal fluid was submitted for cell count.
The authors suggest that additional tests may be indicated in immunocompromised patients due to the potential for atypical disease presentations.
Cell count was one of the basic parameters used to determine whether additional CSF tests were necessary.
Among 148 cases of bacterial, chronic infectious, and malignant meningitis, all but three had abnormal opening pressure, cell count, or protein.
The authors propose that additional CSF tests are rarely indicated when opening pressure, cell count, and protein are normal.